Market revenue in 2023 | USD 172.2 million |
Market revenue in 2030 | USD 482.1 million |
Growth rate | 15.8% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 50.46% in 2023. Horizon Databook has segmented the China neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as increasing prevalence of lifestyle diseases such as obesity & depression, chronic diseases such as migraine & epilepsy, and technological advancements are expected to drive the market. For instance, according to WHO, in 2017, 54 million people in China are diagnosed with depression. Obesity is one of the major risk factors for chronic diseases. According to WHO, in 2016, 14.9% of women and 10.8% of men in China were obese.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account